SCHEMBL988807

SCHEMBL988807

CC(=O)C(Br)CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6761845 0.78 TRPA1 (0.37)
SCHEMBL13991691 0.78 LCK (0.37)
SCHEMBL26520993 0.77
SCHEMBL26450921 0.75
SCHEMBL539353 0.75
SCHEMBL23775550 0.75
SCHEMBL19628871 0.75
SCHEMBL28016360 0.75 ALDH1A1 (0.42)
SCHEMBL27473475 0.73 ALDH1A1 (0.61)
SCHEMBL5149182 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10611746-B2 Method for producing 2-acetyl-4H,9H-naphtho[2,3-B]furan-4,9-dione SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-04-07 US claimed
US-20190263769-A1 METHOD FOR PRODUCING 2-ACETYL-4H,9H-NAPHTHO[2,3-B]FURAN-4,9-DIONE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2019-08-29 US claimed
US-10329267-B2 Method for producing 2-acetyl-4H,9H-naphtho[2,3-b]furan-4,9-dione SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2019-06-25 US claimed
US-20180201597-A1 METHOD FOR PRODUCING 2-ACETYL-4H,9H-NAPHTHO[2,3-B]FURAN-4,9-DIONE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2018-07-19 US claimed
EP-2547334-B1 NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS 1GLOBE BIOMEDICAL CO LTD (CN) 2017-11-15 EP claimed
US-20130034591-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS BOSTON BIOMEDICAL, INC. (US) 2013-02-07 US claimed
EP-2547334-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS Boston Biomedical, Inc. (US) 2013-01-23 EP claimed
WO-2011116398-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS BOSTON BIOMEDICAL, INC. (US) 2011-09-22 WO claimed
EP-2547205-B1 NOVEL METHODS FOR TARGETING CANCER STEM CELLS 1GLOBE BIOMEDICAL CO LTD (CN) 2024-03-20 EP disclosed
CN-107375260-B Novel compounds and compositions for targeting cancer stem cells 北京强新生物科技有限公司 2023-10-24 CN disclosed
CN-115475253-B Lapatinib-cancer cell stem inhibitor conjugate, preparation method, pharmaceutical composition and application 东南大学 2023-09-29 CN disclosed
US-11739074-B2 Ras inhibitors Revolution Medicines, Inc. (US) 2023-08-29 US disclosed
US-20230233569-A1 METHODS FOR DELAYING, PREVENTING, AND TREATING ACQUIRED RESISTANCE TO RAS INHIBITORS WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT 2023-07-27 US disclosed
CN-115475253-A Lapatinib-cancer cell dryness inhibitor conjugate, preparation method, pharmaceutical composition and application 东南大学 2022-12-16 CN disclosed
US-4087488-A Cyano-4-(0,0-dialkylphosphoryloxy)-cyclohex-4-enes HOFFMAN-LA ROCHE INC. (US) 1978-05-02 US disclosed
US-4077985-A 4-(O,O-Diester phosphoryloxy)cyclohex-4-en-1,2-carboxylic anhydrides HOFFMANN-LA ROCHE INC. (US) 1978-03-07 US disclosed
US-4025584-A 1-Acetyl-3(4)-(dihydrocarbylphosphoryloxy)-cyclohex-3-enes HOFFMANN-LA ROCHE INC. (US) 1977-05-24 US disclosed
US-3978171-A PROCESS FOR THE PREPARATION OF DIENYLPHOSPHATES HOFFMANN-LA ROCHE INC. (US) 1976-08-31 US disclosed
US-3978172-A PROCESS FOR THE PREPARATION OF DIENYLPHOSPHATES HOFFMANN-LA ROCHE INC. (US) 1976-08-31 US disclosed
US-3933948-A Dienylphosphates HOFFMANN-LA ROCHE INC. (US) 1976-01-20 US disclosed